D-0623-2017 Class III Terminated
FDA drug recall D-0623-2017 was initiated by Hetero USA Inc on Jan 7, 2017 and is designated Class III. Reason for recall: Discoloration: the firm received a complaint of a sealed bottle in which tablets inside had blue spots and a blue powder inside the bottle. The recall status is terminated (terminated Aug 8, 2017). Affected quantity: 65,664 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 5, 2017
- Initiation Date
- Jan 7, 2017
- Termination Date
- Aug 8, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 65,664 bottles
Product description
Montelukast sodium tablets, 10 mg, 30-count bottle, Rx Only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, By: HETERO Labs Limited, Unit V, Polepally, Jadcherla, Mahaboob Nagar - 509 301, India, NDC 31722-726-30
Reason for recall
Discoloration: the firm received a complaint of a sealed bottle in which tablets inside had blue spots and a blue powder inside the bottle.
Distribution pattern
US Nationwide
Code information
Lot # MON16001B, Exp 01/18
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0623-2017
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026